# US 2011/0237596 A1 · Heteroaryl-substituted urea modulators of fatty acid amide hydrolase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0237596 A1
- Document ID: US20110237596A1
- Status: Published application
- Kind: A1
- Application number: 13/131,067
- Filed: 2009-11-24
- Published: 2011-09-29
- Earliest claimed: 2008-11-25
- Assignees: Jannsen Pharmaceutica, N.V.
- Inventors: J. Guy Breitenbucher; John M. Keith; Mark S. Tichenor; Alison L. Chambers; William M. Jones; Natalie A. Hawryluk; Amy K. Timmons; Jeffrey E. Merit; Mark J. Seierstad
- Web page: https://patentgrep.com/patent/US20110237596A1

## CPC

- C07D 498/04: Ortho-condensed systems
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/12: Antidiarrhoeals
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/12: Antihypertensives
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/22: Anxiolytics
- A61P 25/24: Antidepressants
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 25/30: for treating abuse or dependence
- A61P 27/02: Ophthalmic agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/18: for HIV
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- C07D 231/56: Benzopyrazoles; Hydrogenated benzopyrazoles
- C07D 295/195: Radicals derived from nitrogen analogues of carboxylic acids
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- C07D 471/04: Ortho-condensed systems
- C07D 471/12: in which the condensed system contains three hetero rings
- C07D 487/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis).

## Claims

### Claim 1

A chemical entity selected from compounds of Formula (I):
wherein
Ar1 is isoxazolo[5,4-c]pyridin-3-yl, isoxazolo[4,5-c]pyridin-3-yl, isoxazolo[4,5-b]pyridin-3-yl, isoxazolo[5,4-b]pyridin-3-yl, imidazo[1,2-a]pyridin-8-yl, imidazo[1,2-a]pyridin-7-yl, imidazo[1,2-a]pyridin-6-yl, imidazo[1,2-a]pyridin-5-yl, imidazo[1,2-b]pyridazin-3-yl, imidazo[1,2-a]pyridin-3-yl, imidazo[1,2-a]pyridin-2-yl, imidazo[1,2-a]pyrimidin-7-yl, imidazo[1,2-a]pyrimidin-5-yl, imidazo[1,2-c]pyrimidin-7-yl, benzooxazol-6-yl, 1,1-dioxo-1H-1λ6-benzo[d]isothiazol-3-yl, 1H-pyrrolo[2,3-b]pyridin-5-yl, 1H-pyrrolo[2,3-b]pyridin-4-yl, 1H-pyrrolo[3,2-b]pyridin-6-yl, 1H-pyrazolo[3,4-b]pyridin-5-yl, benzooxazol-5-yl, 1H-indazol-7-yl, 4-chloro-isoxazol-3-yl, or 2H-indazol-4-yl;
where each Ar1 is optionally substituted with one or two groups individually selected from —C1-3alkyl, halo, —CF3, —OC1-3alkyl, or —OCF3;
Z is N or >CH;
Ar2 is
(i) phenyl unsubstituted or substituted with one or two Ra moieties;
where each Ra moiety is independently —C1-8alkyl, —OC1-8alkyl, halo, —CF3, —O(CH2)0-1CF3, —S(O)0-2C1-4alkyl, —S(O)0-2CF3, —(CH2)0-1CO2C1-4alkyl, —CO2H, —N(Rb)Rc, —SO2NRbRc, —C(O)NRbRc, —C≡C—Rd, —NRbSO2Rg, —NO2, —(CH2)1-6—O—C1-6alkyl, —(CH2)1-6—S(O)0-2—C1-6alkyl, or —(CH2)0-1CN;
or two adjacent Ra moieties taken together form —O(CH2)1-2O— or —OCF2O—;
where Rb and Rc are each independently H or —C1-4alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rd is H, —C1-8alkyl, or —CH2NReRf;
where Re and Rf are each independently H or —C1-8alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rg is —H or —C1-4alkyl;
(ii) phenyl substituted at the 3- or 4-position with -L-Ar3, unsubstituted or substituted with one or two Ra moieties, wherein
L is a linker selected from the group consisting of —(CH2)1-6—, —(CH2)0-3—O—(CH2)0-3—, —CH═CH—, —NH—, >NO1-4alkyl, —S(O)0-2—, —C≡C—, —C(O)—, or a covalent bond;
Ar3 is
(a) phenyl unsubstituted or substituted with one or two Ra moieties;
(b) naphthyl unsubstituted or substituted with one or two Ra moieties; or
(c) a monocyclic or bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties; or
(iii) a 9- or 10-membered fused bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties;
and pharmaceutically acceptable salts of compounds of Formula (I), pharmaceutically acceptable prodrugs of compounds of Formula (I), and pharmaceutically active metabolites of compounds of Formula (I).

### Claim 2 (depends on 1)

A chemical entity as in claim 1, wherein Ar1 is isoxazolo[5,4-c]pyridin-3-yl, isoxazolo[4,5-c]pyridin-3-yl, imidazo[1,2-b]pyridazin-3-yl, 1H-pyrrolo[2,3-b]pyridin-5-yl, imidazo[1,2-a]pyridin-5-yl, 6-[1,2,3]triazol-2-yl-pyridin-3-yl, 5-methyl-[1,3,4]oxadiazol-2-yl, imidazo[1,2-a]pyrimidin-5-yl, 4-[1,2,3]triazol-1-yl-phenyl, 4-[1,2,3]triazol-2-yl-phenyl, 2-phenyl-pyrimidin-5-yl, isoxazolo[4,5-b]pyridin-3-yl, 1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl, benzooxazol-6-yl, or 2-methyl-2H-indazol-4-yl.

### Claim 3 (depends on 1)

A chemical entity as in claim 1, wherein Ar1 is isoxazolo[5,4-c]pyridin-3-yl, isoxazolo[4,5-c]pyridin-3-yl, isoxazolo[4,5-b]pyridin-3-yl, imidazo[1,2-b]pyridin-8-yl, imidazo[1,2-a]pyridin-7-yl, imidazo[1,2-a]pyridin-5-yl, imidazo[1,2-a]pyrimidin-7-yl, imidazo[1,2-a]pyrimidin-5-yl, imidazo[1,2-c]pyrimidin-7-yl.

### Claim 4 (depends on 1)

A chemical entity as in claim 1, wherein Z is N.

### Claim 5 (depends on 1)

A chemical entity as in claim 1, wherein Z is >CH.

### Claim 6 (depends on 1)

A chemical entity as in claim 1, wherein Ar2 is phenyl, substituted with one or two Ra moieties.

### Claim 7 (depends on 6)

A chemical entity as in claim 6, wherein each Ra moiety is independently selected from the group consisting of: chloro, fluoro, bromo, —OCF3, CF3, CN, —OC1-8alkyl or two adjacent Ra moieties taken together form —OCH2O— or —OCF2O—.

### Claim 8 (depends on 1)

A chemical entity as in claim 1, wherein Ar2 is benzofuran, indoyl, napthyl, quinoline, or benzthiophene, each optionally unsubstituted or substituted with one or two Ra moieties.

### Claim 9 (depends on 1)

A chemical entity as in claim 1, wherein Ar2 is phenyl substituted at the 3- or 4-position with -L-Ar3, where Ar3 is unsubstituted or substituted with one or two Ra moieties.

### Claim 10 (depends on 9)

A chemical entity as in claim 9, wherein L is —CH2CH2—, —O—, —OCH2—, or —C≡C—.

### Claim 11 (depends on 9)

A chemical entity as in claim 9, wherein L is —O—.

### Claim 12 (depends on 9)

A chemical entity as in claim 9, wherein Ar3 is phenyl, unsubstituted or substituted with one or two Ra moieties.

### Claim 13 (depends on 12)

A chemical entity as in claim 12, wherein each Ra moiety is independently selected from the group consisting of: chloro, cyano, isobutyl, methylsulfanyl, methanesulfonyl, trifluoromethyl, trifluoromethoxy, 2,2,2-trifluoroethoxy, fluoro, methyl, methoxy, tert-butyl, bromo, methoxycarbonyl, cyanomethyl, methoxycarbonylmethyl, trifluoromethanesulfonyl, trifluoromethanesulfanyl, and butyl; or two adjacent Ra moieties taken together form —OCH2O— or —OCF2O—.

### Claim 14 (depends on 12)

A chemical entity as in claim 12, wherein each Ra moiety is independently bromo, chloro, fluoro, CF3, OCF3, CN; or two adjacent Ra moieties taken together form —OCH2O— or —OCF2O—.

### Claim 15

A chemical entity selected from the group consisting of:
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-3-fluoro-benzyl)piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[1,3]dioxol-5-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(1H-Indol-6-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-3-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Fluoro-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethylsulfanyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(Quinolin-6-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Benzyloxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethanesulfonyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dibromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3,4-Difluoro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Phenoxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[b]thiophen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Naphthalen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzofuran-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-{3-[4-(2,2,2-Trifluoro-ethoxy)-phenoxy]-benzyl}-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2,2-Difluoro-benzo[1,3]dioxol-5-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[3,2-b]pyridin-6-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,1-dioxo-1H-1,6-benzo[d]isothiazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1-isopropyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-benzooxazol-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-2H-indazol-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-c]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-5-ylamide;
4-[3-(3-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(4-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)amide;
4-[3-(5-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(6-Trifluoromethyl-pyridazin-3-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperidine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-Quinolin-3-ylmethyl-piperidine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
and pharmaceutically acceptable salts thereof.

### Claim 16

A pharmaceutical composition for treating a disease, disorder, or medical condition mediated by FAAH activity, comprising:
(a) an effective amount of at least one chemical entity selected from compounds of Formula (I):
wherein
Ar1 is isoxazolo[5,4-c]pyridin-3-yl, isoxazolo[4,5-c]pyridin-3-yl, isoxazolo[4,5-b]pyridin-3-yl, isoxazolo[5,4-b]pyridin-3-yl, imidazo[1,2-a]pyridin-8-yl, imidazo[1,2-a]pyridin-7-yl, imidazo[1,2-a]pyridin-6-yl, imidazo[1,2-a]pyridin-5-yl, imidazo[1,2-b]pyridazin-3-yl, imidazo[1,2-a]pyridin-3-yl, imidazo[1,2-a]pyridin-2-yl, imidazo[1,2-a]pyrimidin-7-yl, imidazo[1,2-a]pyrimidin-5-yl, imidazo[1,2-c]pyrimidin-7-yl, benzooxazol-6-yl, 1,1-dioxo-1H-1λ6-benzo[d]isothiazol-3-yl, 1H-pyrrolo[2,3-b]pyridin-5-yl, 1H-pyrrolo[2,3-b]pyridin-4-yl, 1H-pyrrolo[3,2-b]pyridin-6-yl, 1H-pyrazolo[3,4-b]pyridin-5-yl, benzooxazol-5-yl, 1H-indazol-7-yl, 4-chloro-isoxazol-3-yl, or 2H-indazol-4-yl;
where each Ar1 is optionally substituted with one or two groups individually selected from C1-3alkyl, halo, CF3, OC1-3alkyl, or OCF3;
Z is N or >CH;
Ar2 is
(i) phenyl unsubstituted or substituted with one or two Ra moieties;
where each Ra moiety is independently C1-8alkyl, —OC1-8alkyl, halo, —CF3, —O(CH2)0-1CF3, —S(O)0-2C1-4alkyl, —S(O)0-2CF3, —(CH2)0-1CO2C1-4alkyl, —CO2H, —N(Rb)Rc, —SO2NRbRc, —C(O)NRbRc, —C≡C—Rd, —NRbSO2Rg, —NO2, —(CH2)1-6—O—C1-6alkyl, —(CH2)1-6—S(O)0-2—C1-6alkyl, or —(CH2)0-1CN;
or two adjacent Ra moieties taken together form —O(CH2)1-20— or —OCF2O—;
where Rb and Rc are each independently —H or —C1-4alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rd is H, C1-8alkyl, or —CH2NReRf;
where Re and Rf are each independently H or C1-8alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rg is —H or —C1-4alkyl;
(ii) phenyl substituted at the 3- or 4-position with -L-Ar3, unsubstituted or substituted with one or two Ra moieties, wherein
L is a linker selected from the group consisting of —(CH2)1-6—, —(CH2)0-3—O—(CH2)0-3—, —CH═CH—, —NH—, >NC1-4alkyl, —S(O)0-2—, —C≡C—, —C(O)—, or a covalent bond;
Ar3 is
(a) phenyl unsubstituted or substituted with one or two Ra moieties;
(b) naphthyl unsubstituted or substituted with one or two Ra moieties; or
(c) a monocyclic or bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties; or
(iii) a 9- or 10-membered fused bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties;
and pharmaceutically acceptable salts of compounds of Formula (I), pharmaceutically acceptable prodrugs of compounds of Formula (I), and pharmaceutically active metabolites of compounds of Formula (I); and
(b) a pharmaceutically acceptable excipient.

### Claim 17 (depends on 16)

A pharmaceutical composition according to claim 16, wherein said at least one chemical entity is selected from the group consisting of:
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-3-fluoro-benzyl)piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[1,3]dioxol-5-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(1H-Indol-6-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-3-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Fluoro-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethylsulfanyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(Quinolin-6-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Benzyloxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethanesulfonyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dibromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3,4-Difluoro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Phenoxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[b]thiophen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Naphthalen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzofuran-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-{3-[4-(2,2,2-Trifluoro-ethoxy)-phenoxy]-benzyl}-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2,2-Difluoro-benzo[1,3]dioxol-5-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[3,2-b]pyridin-6-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,1-dioxo-1H-1,6-benzo[d]isothiazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1-isopropyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-benzooxazol-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-2H-indazol-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-c]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-5-ylamide;
4-[3-(3-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)amide;
4-[3-(4-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(5-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(6-Trifluoromethyl-pyridazin-3-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperidine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-Quinolin-3-ylmethyl-piperidine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
and pharmaceutically acceptable salts thereof.

### Claim 18 (depends on 16)

A pharmaceutical composition according to claim 16, further comprising: an analgesic selected from the group consisting of opioids and non-steroidal anti-inflammatory drugs.

### Claim 19 (depends on 16)

A pharmaceutical composition according to claim 16, further comprising: an additional active ingredient selected from the group consisting of aspirin, acetaminophen, opioids, ibuprofen, naproxen, COX-2 inhibitors, gabapentin, pregabalin, and tramadol.

### Claim 20

A method of treating a subject suffering from or diagnosed with a disease, disorder, or medical condition mediated by FAAH activity, comprising administering to the subject in need of such treatment an effective amount of at least one chemical entity selected from compounds of Formula (I):
wherein
Ar1 is isoxazolo[5,4-c]pyridin-3-yl, isoxazolo[4,5-c]pyridin-3-yl, isoxazolo[4,5-b]pyridin-3-yl, isoxazolo[5,4-b]pyridin-3-yl, imidazo[1,2-a]pyridin-8-yl, imidazo[1,2-a]pyridin-7-yl, imidazo[1,2-a]pyridin-6-yl, imidazo[1,2-a]pyridin-5-yl, imidazo[1,2-b]pyridazin-3-yl, imidazo[1,2-a]pyridin-3-yl, imidazo[1,2-a]pyridin-2-yl, imidazo[1,2-a]pyrimidin-7-yl, imidazo[1,2-a]pyrimidin-5-yl, imidazo[1,2-c]pyrimidin-7-yl, benzooxazol-6-yl, 1,1-dioxo-1H-1λ6-benzo[d]isothiazol-3-yl, 1H-pyrrolo[2,3-b]pyridin-5-yl, 1H-pyrrolo[2,3-b]pyridin-4-yl, 1H-pyrrolo[3,2-b]pyridin-6-yl, 1H-pyrazolo[3,4-b]pyridin-5-yl, benzooxazol-5-yl, 1H-indazol-7-yl, 4-chloro-isoxazol-3-yl, or 2H-indazol-4-yl;
where each Ar1 is optionally substituted with one or two groups individually selected from C1-3alkyl, halo, CF3, OC1-3alkyl, or OCF3;
Z is N or >CH;
Ar2 is
(i) phenyl unsubstituted or substituted with one or two Ra moieties;
where each Ra moiety is independently C1-8alkyl, —OC1-8alkyl, halo, —CF3, —O(CH2)0-1CF3, —S(O)0-2C1-4alkyl, —S(O)0-2CF3, —(CH2)0-1CO2C1-4alkyl, —CO2H, —N(Rb)Rc, —SO2NRbRc, —C(O)NRbRc, —C≡C—Rd, —NRbSO2Rg, —NO2, —(CH2)1-6—O—C1-6alkyl, —(CH2)1-6—S(O)0-2—C1-6alkyl, or —(CH2)0-1CN;
or two adjacent Ra moieties taken together form —O(CH2)1-2O— or —OCF2O—;
where Rb and Rc are each independently —H or —C1-4alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rd is H, C1-8alkyl, or —CH2NReRf;
where Re and Rf are each independently H or C1-8alkyl or taken together with the atoms of attachment form a 4-8 membered ring;
Rg is —H or —C1-4alkyl;
(ii) phenyl substituted at the 3- or 4-position with -L-Ar3, unsubstituted or substituted with one or two Ra moieties, wherein
L is a linker selected from the group consisting of —(CH2)1-6—, —(CH2)0-3—O—(CH2)0-3—, —CH═CH—, —NH—, >NO1-4alkyl, —S(O)0-2—, —C≡C—, —C(O)—, or a covalent bond;
Ar3 is
(a) phenyl unsubstituted or substituted with one or two Ra moieties;
(b) naphthyl unsubstituted or substituted with one or two Ra moieties; or
(c) a monocyclic or bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties; or
(iii) a 9- or 10-membered fused bicyclic heteroaryl group unsubstituted or substituted with one or two Ra moieties;
and pharmaceutically acceptable salts of compounds of Formula (I), pharmaceutically acceptable prodrugs of compounds of Formula (I), and pharmaceutically active metabolites of compounds of Formula (I).

### Claim 21 (depends on 20)

A method according to claim 20, wherein said at least one chemical entity is selected from the group consisting of:
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-3-fluoro-benzyl)piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[1,3]dioxol-5-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(1H-Indol-6-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-3-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(4-Bromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Quinolin-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Fluoro-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethylsulfanyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(Quinolin-6-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-3-trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Benzyloxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethanesulfonyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3,4-Dibromo-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3,4-Difluoro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-(3-Phenoxy-benzyl)-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzo[b]thiophen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Naphthalen-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethyl-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-Benzofuran-2-ylmethyl-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Cyano-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-{3-[4-(2,2,2-Trifluoro-ethoxy)-phenoxy]-benzyl}-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(2,2-Difluoro-benzo[1,3]dioxol-5-yloxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Bromo-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(3-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Trifluoromethoxy-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-b]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[5,4-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-c]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)piperazine-1-carboxylic acid isoxazolo[4,5-b]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-pyrrolo[3,2-b]pyridin-6-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (1H-indazol-7-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-6-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-8-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,1-dioxo-1H-1,6-benzo[d]isothiazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1-isopropyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-benzooxazol-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (2-methyl-2H-indazol-4-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid benzooxazol-2-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(3-Chloro-4-trifluoromethoxy-benzyl)piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-5-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-c]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-7-ylamide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid imidazo[1,2-a]pyrimidin-5-ylamide;
4-[3-(3-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(4-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(5-Cyano-pyridin-2-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-[3-(6-Trifluoromethyl-pyridazin-3-yloxy)-benzyl]-piperazine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperidine-1-carboxylic acid (1H-pyrrolo[2,3-b]pyridin-5-yl)-amide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-a]pyridin-3-ylamide;
4-(3,4-Dichloro-benzyl)-piperazine-1-carboxylic acid imidazo[1,2-b]pyridazin-3-ylamide;
4-Quinolin-3-ylmethyl-piperidine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-[3-(4-Chloro-phenoxy)-benzyl]-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1-carboxylic acid (4-chloro-isoxazol-3-yl)-amide;
and pharmaceutically acceptable salts thereof.

### Claim 22 (depends on 20)

A method according to claim 20, wherein the disease, disorder, or medical condition is selected from the group consisting of: anxiety, depression, pain, sleep disorders, eating disorders, inflammation, movement disorders, HIV wasting syndrome, closed head injury, stroke, learning and memory disorders, Alzheimer's disease, epilepsy, Tourette's syndrome, Niemann-Pick disease, Parkinson's disease, Huntington's chorea, optic neuritis, autoimmune uveitis, drug withdrawal, nausea, emesis, sexual dysfunction, post-traumatic stress disorder, cerebral vasospasm, glaucoma, irritable bowel syndrome, inflammatory bowel disease, immunosuppression, gastroesophageal reflux disease, paralytic ileus, secretory diarrhea, gastric ulcer, rheumatoid arthritis, unwanted pregnancy, hypertension, cancer, hepatitis, allergic airway disease, autoimmune diabetes, intractable pruritis, and neuroinflammation.

### Claim 23 (depends on 20)

A method according to claim 20, wherein the disease, disorder, or medical condition is pain or inflammation.

### Claim 24 (depends on 20)

A method according to claim 20, wherein the disease, disorder, or medical condition is anxiety, a sleep disorder, an eating disorder, or a movement disorder.

### Claim 25 (depends on 20)

A method according to claim 20, wherein the disease, disorder, or medical condition is multiple sclerosis.

### Claim 26 (depends on 20)

A method according to claim 20, wherein the disease, disorder, or medical condition is energy metabolism or bone homeostasis.
